Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

May 06, 2026 16:05 ET | Source: electroCore, Inc.

electroCore Announces First Quarter 2026 Financial Results

First quarter 2026 net sales of $9.6 million, an increase of 43% over $6.7 million in the first quarter 2025 Net loss of $5.3 million with Adjusted EBITDA net loss improving 24% from prior-year...
April 29, 2026 08:00 ET | Source: electroCore, Inc.

electroCore to Announce First Quarter March 31, 2026, Financial Results on Wednesday, May 6, 2026

ROCKAWAY, N.J., April 29, 2026 (GLOBE NEWSWIRE) -- electroCore, Inc. (Nasdaq: ECOR), a commercial-stage bioelectronic medicine and wellness company, announced today that it will report financial...
April 28, 2026 08:00 ET | Source: electroCore, Inc.

electroCore to Present at the Market Movers Investor Summit on May 5, 2026

ROCKAWAY, N.J., April 28, 2026 (GLOBE NEWSWIRE) -- electroCore, Inc. (Nasdaq: ECOR), a commercial-stage bioelectronic medicine and wellness company, announced today that it will be participating in...
April 23, 2026 08:00 ET | Source: electroCore, Inc.

electroCore Product Line Featured in Documentary Underscoring the Expanding Clinical and Commercial Role of Vagus Nerve Stimulation

ROCKAWAY, N.J., April 23, 2026 (GLOBE NEWSWIRE) -- electroCore, Inc. (Nasdaq: ECOR), a commercial-stage bioelectronic medicine and wellness company, today announced its participation in Hacking the...
April 16, 2026 10:00 ET | Source: Speechmatics Limited

AI can now understand health signals from 15 seconds of your voice, including type 2 diabetes, fatigue and stress

Speechmatics and thymia turn 15 seconds of speech into real-time health signals.
April 08, 2026 08:00 ET | Source: electroCore, Inc.

electroCore to Participate in the 25th Annual Needham Virtual Healthcare Conference

ROCKAWAY, N.J., April 08, 2026 (GLOBE NEWSWIRE) -- electroCore, Inc. (Nasdaq: ECOR), a commercial-stage bioelectronic medicine and wellness company, announced today that management will participate...
April 01, 2026 08:00 ET | Source: electroCore, Inc.

electroCore Announces Publication in Frontiers in Neuroscience Highlighting Benefits of Non-Invasive Vagus Nerve Stimulation in Patients with Mild Traumatic Brain Injury and PTSD

ROCKAWAY, N.J., April 01, 2026 (GLOBE NEWSWIRE) -- electroCore, Inc. (Nasdaq: ECOR), a commercial-stage bioelectronic medicine and wellness company, announced today the publication of new clinical...
March 30, 2026 08:00 ET | Source: electroCore, Inc.

electroCore Expands Intellectual Property Portfolio

ROCKAWAY, N.J., March 30, 2026 (GLOBE NEWSWIRE) -- electroCore, Inc. (Nasdaq: ECOR), a commercial-stage bioelectronic medicine and wellness company, today announced the issuance of two new U.S....
March 19, 2026 16:05 ET | Source: electroCore, Inc.

electroCore Announces Full Year 2025 Financial Results and Organizational Changes

Record full year 2025 net sales of $32.0, an increase of 27% over $25.2 million for the full year 2024 driven by 25% annual growth in our U.S. prescription business and 97% increase in general...
March 10, 2026 08:00 ET | Source: electroCore, Inc.

electroCore to Participate at the 38th Annual Roth Conference

ROCKAWAY, N.J., March 10, 2026 (GLOBE NEWSWIRE) -- electroCore, Inc. (Nasdaq: ECOR), a bioelectronic medicine and wellness company, announced today that management will participate in the 38th...